Novel	O
Model	O
of	O
Tendon	O
Regeneration	O
Reveals	O
Distinct	O
Cell	O
Mechanisms	O
Underlying	O
Regenerative	O
and	O
Fibrotic	O
Tendon	O
Healing	O

To	O
date	O
,	O
the	O
cell	O
and	O
molecular	O
mechanisms	O
regulating	O
tendon	O
healing	O
are	O
poorly	O
understood	O
.	O

Here	O
,	O
we	O
establish	O
a	O
novel	O
model	O
of	O
tendon	O
regeneration	O
using	O
neonatal	O
mice	B-OG
and	O
show	O
that	O
neonates	O
heal	O
via	O
formation	O
of	O
a	O
‘	O
neo	O
-	O
tendon	O
’	O
that	O
differentiates	O
along	O
the	O
tendon	O
specific	O
lineage	O
with	O
functional	O
restoration	O
of	O
gait	O
and	O
mechanical	O
properties	O
.	O

In	O
contrast	O
,	O
adults	O
heal	O
via	O
fibrovascular	O
scar	O
,	O
aberrant	O
differentiation	O
toward	O
cartilage	O
and	O
bone	O
,	O
with	O
persistently	O
impaired	O
function	O
.	O

Lineage	O
tracing	O
identified	O
intrinsic	O
recruitment	O
of	O
Scx	B-GP
-	O
lineage	O
cells	O
as	O
a	O
key	O
cellular	O
mechanism	O
of	O
neonatal	O
healing	O
that	O
is	O
absent	O
in	O
adults	O
.	O

Instead	O
,	O
adult	O
Scx	B-GP
-	O
lineage	O
tenocytes	O
are	O
not	O
recruited	O
into	O
the	O
defect	O
but	O
transdifferentiate	O
into	O
ectopic	O
cartilage	O
;	O
in	O
the	O
absence	O
of	O
tenogenic	O
cells	O
,	O
extrinsic	O
αSMA	B-GP
-	O
expressing	O
cells	O
persist	O
to	O
form	O
a	O
permanent	O
scar	O
.	O

Collectively	O
,	O
these	O
results	O
establish	O
an	O
exciting	O
model	O
of	O
tendon	O
regeneration	O
and	O
uncover	O
a	O
novel	O
cellular	O
mechanism	O
underlying	O
regenerative	O
vs	O
non	O
-	O
regenerative	O
tendon	O
healing	O
.	O

Tendons	O
are	O
dense	O
connective	O
tissues	O
that	O
mediate	O
transfer	O
of	O
muscle	O
forces	O
to	O
the	O
skeleton	O
.	O

This	O
important	O
mechanical	O
function	O
is	O
enabled	O
by	O
a	O
highly	O
organized	O
extracellular	O
matrix	O
primarily	O
composed	O
of	O
aligned	O
type	B-GP
I	I-GP
collagen	I-GP
fibers	O
.	O

With	O
acute	O
injury	O
or	O
tendinopathy	B-DS
,	O
tendon	O
function	O
is	O
often	O
permanently	O
compromised	O
due	O
to	O
poor	O
healing	O
and	O
scarring	O
(	O
defined	O
as	O
disorganized	O
fibrovascular	O
matrix	O
and	O
inferior	O
mechanical	O
properties	O
),	O
leading	O
to	O
chronic	O
pain	O
and	O
prolonged	O
disability1	O
.	O

Despite	O
the	O
high	O
incidence	O
of	O
injures	O
(	O
tendon	O
and	O
ligament	O
injuries	O
affect	O
110	O
million	O
patients	O
in	O
the	O
US	O
alone	O
)	O
2	O
,	O
treatment	O
options	O
remain	O
few	O
with	O
variable	O
success	O
outcomes	O
.	O

To	O
date	O
,	O
the	O
cell	O
and	O
molecular	O
mechanisms	O
that	O
drive	O
tendon	O
differentiation	O
and	O
maturation	O
remain	O
poorly	O
understood	O
.	O

The	O
key	O
transcription	B-GP
factors	I-GP
and	O
signaling	O
pathways	O
identified	O
for	O
tendon	O
were	O
originally	O
discovered	O
from	O
studies	O
of	O
embryonic	O
development3456	O
.	O

Of	O
these	O
transcription	B-GP
factors	I-GP
,	O
Scleraxis	B-GP
(	O
Scx	B-GP
),	O
is	O
still	O
the	O
earliest	O
known	O
marker	O
expressed	O
by	O
tendon	O
progenitors	O
,	O
while	O
Mohawk	B-GP
(	O
Mkx	B-GP
)	O
is	O
a	O
key	O
regulator	O
of	O
postnatal	O
collagen	B-GP
maturation78910	O
.	O

While	O
significant	O
progress	O
has	O
been	O
made	O
in	O
understanding	O
tendon	O
development	O
,	O
the	O
biological	O
events	O
that	O
orchestrate	O
tendon	O
differentiation	O
,	O
maturation	O
,	O
and	O
scar	O
formation	O
in	O
the	O
context	O
of	O
healing	O
are	O
still	O
largely	O
unknown	O
.	O

Most	O
of	O
the	O
existing	O
research	O
in	O
tendon	O
healing	O
has	O
been	O
carried	O
out	O
using	O
adult	O
animal	B-OG
models	O
that	O
heal	O
via	O
the	O
default	O
pathway	O
of	O
fibrovascular	O
scar	O
.	O

However	O
,	O
the	O
cells	O
that	O
regulate	O
fibrotic	O
tendon	O
healing	O
have	O
not	O
been	O
fully	O
defined	O
since	O
lineage	O
tracing	O
studies	O
in	O
this	O
context	O
are	O
few	O
.	O

The	O
paucity	O
of	O
tendon	O
regeneration	O
models	O
is	O
also	O
a	O
major	O
limitation	O
,	O
since	O
regenerative	O
healing	O
will	O
likely	O
involve	O
cellular	O
players	O
,	O
signaling	O
pathways	O
,	O
and	O
unique	O
mechanical	O
and	O
immune	O
environments	O
that	O
are	O
absent	O
during	O
development	O
.	O

The	O
neonatal	O
mouse	B-OG
recently	O
emerged	O
as	O
an	O
exciting	O
model	O
of	O
mammalian	O
regeneration	O
for	O
the	O
heart	O
,	O
which	O
heals	O
by	O
scar	O
in	O
the	O
adult11	O
.	O

A	O
few	O
studies	O
in	O
other	O
tissue	O
systems	O
(	O
cochlear	O
hair	O
cells	O
and	O
digit	O
tips	O
)	O
suggest	O
that	O
this	O
neonatal	O
regenerative	O
capacity	O
may	O
extend	O
to	O
a	O
wide	O
range	O
of	O
tissues	O
,	O
although	O
this	O
remains	O
unconfirmed	O
for	O
most	O
tissues12131415	O
.	O

Although	O
one	O
intriguing	O
study	O
for	O
tendon	O
showed	O
restoration	O
of	O
mechanical	O
properties	O
one	O
week	O
after	O
neonatal	O
injury	O
,	O
the	O
cells	O
that	O
mediate	O
healing	O
were	O
not	O
determined16	O
.	O

In	O
this	O
study	O
,	O
we	O
address	O
this	O
limitation	O
in	O
the	O
field	O
and	O
show	O
for	O
the	O
first	O
time	O
that	O
neonatal	O
tendon	O
has	O
regenerative	O
capacity	O
,	O
with	O
full	O
restoration	O
of	O
function	O
and	O
tendon	O
-	O
specific	O
differentiation	O
after	O
injury	O
.	O

Using	O
genetic	O
tools	O
,	O
we	O
further	O
show	O
that	O
tendon	O
regeneration	O
is	O
driven	O
by	O
two	O
cell	O
populations	O
:	O
1	O
)	O
an	O
early	O
population	O
of	O
extrinsic	O
αSMA	B-GP
cells	O
that	O
are	O
transiently	O
recruited	O
and	O
2	O
)	O
intrinsic	O
tenocytes	O
that	O
proliferate	O
and	O
differentiate	O
to	O
regenerate	O
the	O
tendon	O
.	O

In	O
adults	O
,	O
tendon	O
cells	O
undergo	O
aberrant	O
differentiation	O
toward	O
cartilage	O
and	O
are	O
not	O
recruited	O
into	O
the	O
defect	O
;	O
in	O
the	O
absence	O
of	O
tenogenic	O
cells	O
,	O
extrinsic	O
fibrotic	O
cells	O
persist	O
to	O
form	O
a	O
permanent	O
scar	O
.	O

Collectively	O
,	O
these	O
results	O
establish	O
exciting	O
models	O
of	O
regenerative	O
and	O
non	O
-	O
regenerative	O
tendon	O
healing	O
in	O
a	O
genetically	O
tractable	O
background	O
,	O
and	O
define	O
a	O
potential	O
cellular	O
mechanism	O
for	O
improving	O
adult	O
tendon	O
healing	O
.	O

Results	O

Neonatal	O
tendon	O
heals	O
via	O
regeneration	O
of	O
ScxGFP	O
+	O
‘	O
neo	O
-	O
tendon	O
’	O

To	O
test	O
whether	O
neonatal	O
tendons	O
are	O
capable	O
of	O
regeneration	O
,	O
we	O
used	O
a	O
simple	O
transection	O
injury	O
.	O

For	O
all	O
animals	B-OG
,	O
Achilles	O
tendon	O
transection	O
resulted	O
in	O
immediate	O
retraction	O
of	O
the	O
divided	O
tendon	O
stubs	O
leaving	O
an	O
empty	O
gap	O
space	O
in	O
between	O
(	O
Fig	O
.	O
1A	O
).	O

At	O
day	O
3	O
(	O
d3	O
)	O
after	O
tendon	O
transection	O
,	O
the	O
injured	O
limb	O
in	O
neonates	O
appeared	O
drastically	O
impaired	O
;	O
pups	O
were	O
unable	O
to	O
maintain	O
normal	O
posture	O
on	O
the	O
injured	O
limb	O
and	O
ambulation	O
was	O
achieved	O
predominantly	O
by	O
weight	O
bearing	O
on	O
the	O
injured	O
heel	O
/	O
ankle	O
instead	O
of	O
toes	O
(	O
Fig	O
.	O
1B	O
and	O
Supplementary	O
Videos	O
S1	O
,	O
S2	O
,	O
S3	O
,	O
S4	O
).	O

By	O
d14	O
however	O
,	O
neonatal	O
mice	B-OG
were	O
fully	O
mobile	O
and	O
qualitative	O
differences	O
between	O
injured	O
and	O
uninjured	O
limbs	O
were	O
no	O
longer	O
obvious	O
(	O
Fig	O
.	O
1B	O
).	O

At	O
the	O
tissue	O
level	O
,	O
whole	O
mount	O
imaging	O
of	O
ScxGFP	O
hindlimbs	O
at	O
d3	O
showed	O
that	O
ScxGFP	O
expression	O
was	O
restricted	O
to	O
the	O
original	O
tendon	O
stubs	O
and	O
that	O
the	O
gap	O
space	O
was	O
devoid	O
of	O
ScxGFP	O
+	O
cells	O
.	O

By	O
d14	O
in	O
the	O
neonatal	O
group	O
,	O
a	O
continuous	O
and	O
aligned	O
ScxGFP	O
+‘	O
neo	O
-	O
tendon	O
’	O
had	O
formed	O
within	O
the	O
gap	O
space	O
,	O
connecting	O
the	O
original	O
tendon	O
stubs	O
,	O
suggesting	O
that	O
rapid	O
regeneration	O
of	O
tendon	O
may	O
be	O
possible	O
in	O
neonates	O
(	O
Fig	O
.	O
1C	O
,	O
D	O
).	O

In	O
adult	O
limbs	O
,	O
we	O
found	O
that	O
ScxGFP	O
expression	O
was	O
downregulated	O
in	O
tendon	O
following	O
skeletal	O
maturity	O
,	O
although	O
low	O
expression	O
was	O
still	O
detectable	O
relative	O
to	O
non	O
-	O
tendon	O
tissues	O
.	O

Surprisingly	O
,	O
at	O
d14	O
after	O
adult	O
injury	O
,	O
dramatic	O
re	O
-	O
activation	O
of	O
ScxGFP	O
was	O
observed	O
,	O
but	O
only	O
in	O
the	O
original	O
tendon	O
stubs	O
(	O
non	O
-	O
injured	O
tendons	O
adjacent	O
to	O
the	O
Achilles	O
were	O
not	O
affected	O
)	O
(	O
Fig	O
.	O
1E	O
).	O

Although	O
the	O
gap	O
space	O
was	O
also	O
filled	O
by	O
new	O
tissue	O
at	O
d14	O
in	O
adults	O
,	O
this	O
tissue	O
did	O
not	O
express	O
ScxGFP	O
.	O

Thus	O
,	O
in	O
contrast	O
to	O
our	O
findings	O
in	O
neonates	O
,	O
tendon	O
transection	O
injury	O
in	O
adult	O
tendons	O
healed	O
via	O
formation	O
of	O
ScxGFP	O
-	O
negative	O
tissue	O
bridging	O
the	O
tendon	O
stubs	O
,	O
suggesting	O
there	O
are	O
distinct	O
cellular	O
mechanisms	O
that	O
regulate	O
neonatal	O
vs	O
adult	O
tendon	O
healing	O
.	O

Tendon	O
-	O
specific	O
differentiation	O
during	O
neonatal	O
healing	O
and	O
neo	O
-	O
tendon	O
formation	O

To	O
test	O
whether	O
neonatal	O
healing	O
is	O
tendon	O
-	O
specific	O
,	O
we	O
evaluated	O
the	O
expression	O
of	O
several	O
markers	O
associated	O
with	O
tendon	O
,	O
cartilage	O
,	O
bone	O
,	O
or	O
fat	O
differentiation	O
from	O
d3	O
thru	O
d28	O
after	O
injury	O
.	O

Real	O
time	O
qPCR	O
showed	O
enhanced	O
expression	O
of	O
all	O
tendon	O
markers	O
after	O
neonatal	O
injury	O
,	O
with	O
significant	O
differences	O
in	O
tendon	O
differentiation	O
markers	O
Scx	B-GP
and	O
Tnmd	B-GP
at	O
d14	O
and	O
d28	O
(	O
p	O
<	O
0	O
.	O
05	O
vs	O
control	O
)	O
(	O
Fig	O
.	O
2A	O
).	O

Interestingly	O
,	O
tendon	O
markers	O
associated	O
with	O
collagen	B-GP
fibrillogenesis	O
,	O
such	O
as	O
Mkx	B-GP
and	O
Col1a1	B-GP
,	O
were	O
not	O
significantly	O
upregulated	O
until	O
d28	O
(	O
p	O
<	O
0	O
.	O
05	O
vs	O
control	O
)	O
(	O
Fig	O
.	O
2A	O
).	O

Overall	O
,	O
while	O
control	O
samples	O
did	O
not	O
vary	O
across	O
timepoints	O
for	O
any	O
of	O
the	O
genes	O
assayed	O
,	O
injured	O
samples	O
increased	O
expression	O
over	O
time	O
(	O
p	O
<	O
0	O
.	O
05	O
d3	O
vs	O
d28	O
).	O

Markers	O
for	O
osteogenesis	O
(	O
Ocn	B-GP
),	O
chondrogenesis	O
(	O
Col2a1	B-GP
),	O
and	O
adipogenesis	O
(	O
Cfd	B-GP
)	O
were	O
not	O
significantly	O
upregulated	O
after	O
injury	O
at	O
any	O
timepoint	O
investigated	O
(	O
Fig	O
.	O
2B	O
).	O

Transient	O
upregulation	O
of	O
scar	O
-	O
associated	O
markers	O
(	O
α	B-GP
-	I-GP
SMA	I-GP
,	O
Fb1	B-GP
,	O
and	O
Col3a1	B-GP
)	O
was	O
observed	O
,	O
beginning	O
at	O
d7	O
,	O
before	O
returning	O
to	O
control	O
levels	O
by	O
d28	O
(	O
Fig	O
.	O
2C	O
).	O

Finally	O
,	O
analysis	O
of	O
adult	O
tendons	O
showed	O
that	O
tendon	O
markers	O
were	O
not	O
significantly	O
upregulated	O
after	O
injury	O
at	O
any	O
timepoint	O
.	O

Indeed	O
,	O
we	O
found	O
down	O
-	O
regulation	O
of	O
Scx	B-GP
(	O
trend	O
,	O
p	O
=	O
0	O
.	O
076	O
)	O
and	O
Mkx	B-GP
(	O
p	O
<	O
0	O
.	O
05	O
)	O
at	O
d14	O
compared	O
to	O
control	O
(	O
Table	O
S1	O
).	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
neonatal	O
tendon	O
regeneration	O
progresses	O
through	O
transient	O
expression	O
of	O
fibrotic	O
markers	O
followed	O
by	O
tendon	O
-	O
specific	O
differentiation	O
.	O

Our	O
results	O
also	O
show	O
that	O
aberrant	O
differentiation	O
toward	O
alternative	O
mesenchymal	O
lineages	O
does	O
not	O
occur	O
during	O
neonatal	O
healing	O
.	O

Functional	O
gait	O
and	O
mechanical	O
properties	O
are	O
restored	O
during	O
neonatal	O
tendon	O
healing	O

To	O
determine	O
whether	O
functional	O
properties	O
are	O
restored	O
after	O
tendon	O
injury	O
,	O
we	O
quantified	O
hindlimb	O
gait	O
and	O
tendon	O
mechanical	O
properties	O
(	O
Fig	O
.	O
3	O
).	O

To	O
identify	O
reproducible	O
parameters	O
associated	O
with	O
injury	O
,	O
we	O
evaluated	O
adult	O
injured	O
mice	B-OG
3	O
days	O
after	O
injury	O
.	O

The	O
d3	O
timepoint	O
was	O
chosen	O
since	O
both	O
neonates	O
and	O
adults	O
were	O
visibly	O
impaired	O
at	O
this	O
time	O
;	O
we	O
focused	O
on	O
adults	O
since	O
neonates	O
at	O
this	O
timepoint	O
(	O
P8	O
)	O
were	O
still	O
too	O
immature	O
to	O
walk	O
consistently	O
on	O
the	O
treadmill	O
.	O

Comparing	O
non	O
-	O
injured	O
control	O
animals	B-OG
and	O
injured	O
animals	B-OG
(	O
in	O
which	O
the	O
right	O
Achilles	O
tendon	O
was	O
transected	O
),	O
we	O
identified	O
three	O
parameters	O
that	O
were	O
significantly	O
different	O
in	O
injured	O
limbs	O
:	O
%	O
Swing	O
Stride	O
,	O
%	O
Brake	O
Stride	O
,	O
and	O
%	O
Propel	O
Stride	O
(	O
since	O
male	O
and	O
female	O
mice	B-OG
were	O
used	O
,	O
all	O
parameters	O
were	O
normalized	O
by	O
Stride	O
length	O
to	O
minimize	O
differences	O
due	O
to	O
animal	B-OG
size	O
/	O
age	O
).	O

The	O
Achilles	O
tendon	O
primarily	O
functions	O
in	O
planar	O
flexion	O
,	O
which	O
regulates	O
the	O
propulsive	O
or	O
‘	O
lift	O
-	O
off	O
’	O
phase	O
of	O
gait	O
;	O
thus	O
%	O
Propel	O
Stride	O
is	O
the	O
parameter	O
most	O
specific	O
for	O
Achilles	O
function	O
.	O

For	O
all	O
three	O
parameters	O
,	O
the	O
injured	O
(	O
right	O
)	O
hindlimb	O
was	O
significantly	O
impaired	O
compared	O
to	O
the	O
contralateral	O
control	O
(	O
left	O
)	O
hindlimb	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Fig	O
.	O
3C	O
).	O

While	O
%	O
Swing	O
Stride	O
was	O
recovered	O
in	O
both	O
adult	O
and	O
neonatal	O
injury	O
groups	O
by	O
day	O
14	O
,	O
%	O
Brake	O
Stride	O
and	O
%	O
Propel	O
Stride	O
remained	O
significantly	O
abnormal	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Fig	O
.	O
3C	O
,	O
D	O
).	O

However	O
,	O
the	O
difference	O
between	O
left	O
and	O
right	O
hindlimbs	O
was	O
already	O
much	O
reduced	O
in	O
the	O
injured	O
neonatal	O
group	O
compared	O
to	O
adult	O
for	O
both	O
parameters	O
,	O
indicating	O
more	O
rapid	O
recovery	O
(	O
neonate	O
vs	O
adult	O
;	O
%	O
Brake	O
Stride	O
:	O
25	O
%	O
vs	O
50	O
%	O
diff	O
;	O
%	O
Propel	O
Stride	O
:	O
17	O
%	O
vs	O
25	O
%	O
diff	O
).	O

By	O
day	O
28	O
,	O
all	O
gait	O
parameters	O
were	O
normal	O
in	O
the	O
injured	O
neonatal	O
group	O
,	O
while	O
%	O
Propel	O
Stride	O
remained	O
significantly	O
abnormal	O
for	O
the	O
adult	O
injured	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Fig	O
.	O
3C	O
,	O
D	O
).	O

Note	O
that	O
no	O
differences	O
were	O
ever	O
detected	O
between	O
left	O
and	O
right	O
hindlimbs	O
of	O
non	O
-	O
injured	O
,	O
age	O
-	O
matched	O
control	O
mice	B-OG
at	O
any	O
timepoint	O
(	O
p	O
>	O
0	O
.	O
1	O
;	O
Supplementary	O
Fig	O
.	O

S1	O
).	O

As	O
an	O
additional	O
test	O
for	O
tendon	O
function	O
,	O
we	O
also	O
carried	O
out	O
direct	O
mechanical	O
testing	O
to	O
determine	O
tensile	O
properties	O
at	O
d56	O
after	O
injury	O
(	O
Fig	O
.	O
3E	O
).	O

Consistent	O
with	O
previous	O
reports	O
in	O
the	O
literature	O
,	O
adult	O
tendons	O
did	O
not	O
fully	O
regain	O
mechanical	O
properties	O
after	O
injury	O
.	O

While	O
maximum	O
force	O
was	O
recovered	O
for	O
both	O
groups	O
,	O
we	O
found	O
that	O
the	O
tensile	O
stiffness	O
of	O
adult	O
tendon	O
remained	O
significantly	O
lower	O
after	O
injury	O
compared	O
to	O
the	O
contralateral	O
control	O
tendon	O
;	O
elongation	O
at	O
yield	O
was	O
also	O
abnormal	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Fig	O
.	O
3E	O
).	O

Strikingly	O
,	O
the	O
tensile	O
properties	O
of	O
neonatal	O
injured	O
tendons	O
were	O
all	O
fully	O
restored	O
by	O
d56	O
(	O
p	O
>	O
0	O
.	O
1	O
,	O
Fig	O
.	O
3E	O
).	O

Taken	O
together	O
,	O
this	O
data	O
suggests	O
that	O
neonatal	O
tendons	O
heal	O
more	O
rapidly	O
compared	O
to	O
adult	O
tendons	O
,	O
with	O
complete	O
restoration	O
of	O
functional	O
properties	O
.	O

Extracellular	O
matrix	O
composition	O
and	O
collagen	B-GP
fibril	O
ultrastructure	O
is	O
improved	O
after	O
neonatal	O
injury	O
compared	O
to	O
adults	O

To	O
determine	O
matrix	O
ultrastructure	O
and	O
organization	O
,	O
we	O
used	O
transmission	O
electron	O
microscopy	O
(	O
TEM	O
)	O
imaging	O
of	O
transverse	O
sections	O
through	O
the	O
tendon	O
mid	O
-	O
substance	O
.	O

Neonatal	O
tendon	O
matrix	O
at	O
d56	O
after	O
injury	O
was	O
uniformly	O
collagenous	O
,	O
similar	O
to	O
control	O
(	O
although	O
higher	O
cellular	O
density	O
was	O
observed	O
)	O
(	O
Fig	O
.	O
4A	O
).	O

In	O
contrast	O
,	O
adult	O
tendon	O
matrix	O
at	O
d56	O
after	O
injury	O
was	O
less	O
organized	O
,	O
with	O
regions	O
of	O
noncollagenous	O
matrix	O
(	O
Fig	O
.	O
4B	O
,	O
red	O
arrows	O
).	O

Quantification	O
of	O
fibril	O
diameter	O
showed	O
that	O
by	O
d56	O
,	O
collagen	B-GP
fibril	O
diameter	O
was	O
smaller	O
in	O
injured	O
tendon	O
compared	O
to	O
respective	O
controls	O
.	O

Fibril	O
diameters	O
in	O
both	O
injured	O
tendon	O
groups	O
were	O
also	O
far	O
more	O
homogeneous	O
,	O
although	O
fibrils	O
in	O
the	O
neonatal	O
group	O
showed	O
a	O
slight	O
shift	O
toward	O
fibrils	O
of	O
larger	O
sizes	O
(~	O
3x	O
the	O
number	O
of	O
>	O
60	O
nm	O
fibrils	O
)	O
compared	O
to	O
adult	O
injury	O
tendons	O
,	O
which	O
had	O
a	O
higher	O
population	O
of	O
smaller	O
sized	O
fibrils	O
(	O
2x	O
the	O
number	O
of	O
<	O
60	O
nm	O
fibrils	O
)	O
(	O
Fig	O
.	O
4C	O
,	O
D	O
).	O

Picrosirius	O
red	O
staining	O
and	O
polarized	O
light	O
imaging	O
of	O
longitudinal	O
plastic	O
sections	O
also	O
confirmed	O
a	O
high	O
degree	O
of	O
collagen	B-GP
alignment	O
at	O
d56	O
.	O

Consistent	O
with	O
the	O
TEM	O
results	O
,	O
the	O
green	O
color	O
for	O
injured	O
tendon	O
indicated	O
abundance	O
of	O
smaller	O
collagen	B-GP
fibrils	O
compared	O
to	O
the	O
orange	O
/	O
red	O
color	O
indicating	O
larger	O
diameter	O
fibrils	O
in	O
the	O
contralateral	O
control	O
(	O
Fig	O
.	O
4E	O
).	O

The	O
homogeneous	O
distribution	O
of	O
small	O
diameter	O
collagen	B-GP
fibrils	O
in	O
injured	O
tendons	O
is	O
similar	O
to	O
the	O
appearance	O
of	O
tendon	O
matrix	O
during	O
embryonic	O
and	O
early	O
postnatal	O
stages10	O
,	O
indicating	O
that	O
collagen	B-GP
maturation	O
is	O
not	O
achieved	O
in	O
either	O
group	O
even	O
after	O
56	O
days	O
of	O
healing	O
.	O

Since	O
type	B-GP
III	I-GP
collagen	I-GP
is	O
a	O
known	O
regulator	O
of	O
type	B-GP
I	I-GP
collagen	I-GP
fibrillogenesis	O
(	O
type	B-GP
I	I-GP
collagen	I-GP
fibrils	O
in	O
Col3a1	B-GP
null	O
skin	O
are	O
much	O
larger	O
in	O
size	O
with	O
heterogeneous	O
distribution	O
)	O
17	O
,	O
we	O
considered	O
the	O
possibility	O
that	O
the	O
sustained	O
shift	O
toward	O
small	O
collagen	B-GP
fibrils	O
after	O
injury	O
is	O
due	O
to	O
overabundance	O
of	O
type	B-GP
III	I-GP
collagen	I-GP
.	O

The	O
sustained	O
presence	O
of	O
type	B-GP
III	I-GP
collagen	I-GP
has	O
also	O
been	O
previously	O
reported	O
in	O
studies	O
of	O
adult	O
tendon	O
injury	O
.	O

We	O
therefore	O
immunostained	O
for	O
type	B-GP
III	I-GP
collagen	I-GP
at	O
d56	O
,	O
however	O
comparable	O
staining	O
was	O
observed	O
between	O
control	O
and	O
injured	O
tendons	O
in	O
the	O
neonatal	O
group	O
(	O
Fig	O
.	O
4F	O
).	O

Immunostaining	O
for	O
type	B-GP
I	I-GP
collagen	I-GP
confirmed	O
that	O
the	O
majority	O
of	O
collagen	B-GP
present	O
in	O
the	O
regenerated	O
tendon	O
is	O
type	O
I	O
(	O
Fig	O
.	O
4G	O
).	O

Overall	O
,	O
these	O
results	O
indicate	O
that	O
neonatal	O
tendon	O
structure	O
is	O
more	O
organized	O
after	O
injury	O
compared	O
to	O
adults	O
,	O
with	O
larger	O
collagen	B-GP
fibrils	O
.	O

However	O
,	O
despite	O
improved	O
organization	O
,	O
the	O
collagen	B-GP
matrix	O
ultrastructure	O
in	O
the	O
neonatal	O
group	O
remained	O
immature	O
56	O
days	O
after	O
injury	O
,	O
indicating	O
some	O
structural	O
limitations	O
to	O
neonatal	O
regeneration	O
.	O

Infiltration	O
of	O
αSMA	B-GP
expressing	O
cells	O
during	O
healing	O

Since	O
the	O
epitenon	O
(	O
an	O
epithelial	O
layer	O
surrounding	O
tendon	O
)	O
has	O
been	O
implicated	O
in	O
adult	O
tendon	O
healing1819	O
,	O
we	O
immunostained	O
for	O
two	O
markers	O
associated	O
with	O
the	O
epitenon	O
(	O
laminin	B-GP
and	O
αSMA	B-GP
)	O
and	O
confirmed	O
positive	O
epitenon	O
staining	O
surrounding	O
neonatal	O
and	O
adult	O
control	O
tendons	O
(	O
Fig	O
.	O
5A	O
–	O
D	O
).	O

Notably	O
,	O
tenocytes	O
were	O
not	O
labeled	O
by	O
either	O
marker	O
(	O
Supplementary	O
Fig	O
.	O

S2	O
).	O

At	O
d14	O
,	O
we	O
observed	O
intense	O
staining	O
of	O
both	O
markers	O
within	O
the	O
adult	O
tendon	O
scar	O
,	O
with	O
only	O
limited	O
staining	O
in	O
the	O
neonatal	O
neo	O
-	O
tendon	O
(	O
Fig	O
.	O
5B	O
,	O
D	O
).	O

Immunostaining	O
for	O
αSMA	B-GP
also	O
revealed	O
the	O
presence	O
of	O
numerous	O
blood	O
vessels	O
populating	O
the	O
adult	O
scar	O
tissue	O
,	O
while	O
αSMA	B-GP
+	O
blood	O
vessels	O
were	O
never	O
observed	O
in	O
the	O
neo	O
-	O
tendon	O
.	O

Interestingly	O
,	O
immunostaining	O
at	O
d3	O
after	O
neonatal	O
injury	O
showed	O
abundant	O
αSMA	B-GP
+	O
cells	O
within	O
the	O
gap	O
space	O
and	O
infiltrating	O
the	O
tendon	O
stubs	O
near	O
the	O
cut	O
site	O
;	O
however	O
,	O
at	O
this	O
timepoint	O
the	O
αSMA	B-GP
+	O
cells	O
were	O
completely	O
ScxGFP	O
-	O
negative	O
,	O
suggesting	O
αSMA	B-GP
+	O
cells	O
are	O
a	O
separate	O
population	O
of	O
cells	O
transiently	O
recruited	O
after	O
neonatal	O
tendon	O
injury	O
(	O
Fig	O
.	O
6A	O
,	O
B	O
).	O

Lineage	O
tracing	O
reveals	O
activation	O
and	O
recruitment	O
of	O
tenocytes	O
after	O
neonatal	O
injury	O

The	O
transient	O
presence	O
of	O
αSMA	B-GP
+	O
cells	O
between	O
d3	O
and	O
d14	O
in	O
neonates	O
initially	O
suggested	O
that	O
αSMA	B-GP
cells	O
may	O
represent	O
a	O
progenitor	O
population	O
recruited	O
from	O
the	O
epitenon	O
.	O

However	O
,	O
we	O
also	O
detected	O
abundant	O
proliferation	O
of	O
ScxGFP	O
+	O
cells	O
by	O
EdU	O
,	O
that	O
was	O
largely	O
concentrated	O
near	O
the	O
cut	O
ends	O
at	O
d3	O
,	O
suggesting	O
that	O
intrinsic	O
tenocytes	O
may	O
play	O
a	O
role	O
in	O
neonatal	O
healing	O
(	O
Fig	O
.	O
7A	O
,	O
B	O
).	O

In	O
contrast	O
,	O
ScxGFP	O
+	O
tenocytes	O
in	O
adults	O
remained	O
quiescent	O
after	O
injury	O
;	O
EdU	O
labeling	O
detected	O
only	O
ScxGFP	O
-	O
cells	O
extrinsic	O
to	O
the	O
tendon	O
and	O
within	O
the	O
gap	O
space	O
at	O
d3	O
(	O
Fig	O
.	O
7C	O
).	O

Quantification	O
of	O
cell	O
proliferation	O
within	O
the	O
neonatal	O
tendon	O
stub	O
confirmed	O
that	O
24	O
%	O
of	O
cells	O
(	O
labeled	O
by	O
DAPI	O
)	O
were	O
proliferating	O
after	O
injury	O
,	O
compared	O
to	O
only	O
3	O
%	O
in	O
the	O
control	O
tendon	O
.	O

Of	O
the	O
proliferating	O
EdU	O
+	O
cells	O
in	O
the	O
injured	O
tendon	O
,	O
the	O
majority	O
(~	O
65	O
%)	O
were	O
ScxGFP	O
+	O
in	O
neonates	O
while	O
0	O
%	O
of	O
proliferating	O
cells	O
in	O
adults	O
were	O
ScxGFP	O
+	O
(	O
Fig	O
.	O
7D	O
,	O
E	O
).	O

To	O
determine	O
the	O
source	O
of	O
the	O
cells	O
driving	O
neonatal	O
vs	O
adult	O
tendon	O
healing	O
,	O
we	O
next	O
used	O
an	O
inducible	O
ScxCreERT2	O
line	O
combined	O
with	O
the	O
Rosa26	O
-	O
TdTomato	B-GP
(	O
RosaT	O
)	O
Cre	B-GP
reporter	O
to	O
label	O
tenocytes	O
with	O
tamoxifen	O
prior	O
to	O
injury	O
.	O

If	O
healing	O
is	O
driven	O
by	O
intrinsic	O
tenocytes	O
,	O
we	O
would	O
expect	O
to	O
find	O
RosaT	O
+	O
cells	O
within	O
the	O
neo	O
-	O
tendon	O
or	O
scar	O
region	O
;	O
conversely	O
,	O
if	O
healing	O
is	O
driven	O
by	O
extrinsic	O
cells	O
,	O
RosaT	O
+	O
cells	O
would	O
not	O
be	O
recruited	O
into	O
the	O
defect	O
(	O
Fig	O
.	O
8A	O
).	O

At	O
d14	O
and	O
d28	O
after	O
neonatal	O
injury	O
,	O
analysis	O
of	O
whole	O
mount	O
limbs	O
and	O
transverse	O
sections	O
showed	O
that	O
the	O
ScxGFP	O
+	O
neo	O
-	O
tendon	O
was	O
strongly	O
composed	O
of	O
RosaT	O
+	O
cells	O
,	O
suggesting	O
that	O
the	O
neo	O
-	O
tendon	O
is	O
derived	O
from	O
Scx	B-GP
-	O
lineage	O
(	O
Scxlin	O
)	O
tenoyctes	O
that	O
are	O
recruited	O
from	O
the	O
original	O
tendon	O
stubs	O
(	O
Fig	O
.	O
8B	O
,	O
C	O
).	O

In	O
adults	O
,	O
we	O
found	O
no	O
RosaT	O
+	O
cells	O
in	O
the	O
ScxGFP	O
-	O
neg	O
scar	O
at	O
d14	O
or	O
d28	O
,	O
despite	O
the	O
presence	O
of	O
numerous	O
cells	O
in	O
this	O
region	O
(	O
indicated	O
by	O
DAPI	O
stained	O
nuclei	O
)	O
(	O
Fig	O
.	O
8D	O
,	O
E	O
).	O

EdU	O
labeling	O
of	O
ScxCreERT2	O
;	O
RosaT	O
;	O
ScxGFP	O
injured	O
limbs	O
at	O
d3	O
revealed	O
abundant	O
proliferating	O
Scxlin	O
cells	O
within	O
the	O
injured	O
tendon	O
stub	O
(	O
red	O
arrow	O
),	O
however	O
the	O
proliferating	O
cells	O
within	O
the	O
gap	O
space	O
were	O
not	O
Scxlin	O
(	O
Fig	O
.	O
8F	O
,	O
G	O
).	O

Adjacent	O
non	O
-	O
injured	O
tendons	O
showed	O
minimal	O
or	O
no	O
proliferation	O
(	O
orange	O
arrows	O
).	O

Systematic	O
analysis	O
and	O
quantification	O
of	O
alternating	O
transverse	O
sections	O
from	O
the	O
skeletal	O
insertion	O
to	O
the	O
gap	O
space	O
indicated	O
enhanced	O
cell	O
proliferation	O
in	O
tendon	O
sections	O
near	O
the	O
transection	O
site	O
(	O
Fig	O
.	O
8G	O
,	O
H	O
).	O
Scxlin	O
cells	O
were	O
localized	O
completely	O
to	O
the	O
tendon	O
stubs	O
and	O
RosaT	O
+	O
cells	O
were	O
not	O
observed	O
in	O
the	O
gap	O
.	O

Immunostaining	O
for	O
αSMA	B-GP
also	O
showed	O
that	O
the	O
αSMA	B-GP
+	O
cells	O
present	O
at	O
d3	O
were	O
not	O
derived	O
from	O
Scxlin	O
tenocytes	O
(	O
Fig	O
.	O
8G	O
).	O

Finally	O
,	O
we	O
considered	O
the	O
possibility	O
that	O
cell	O
survival	O
in	O
neonatal	O
tendons	O
after	O
injury	O
may	O
enable	O
tenocyte	O
recruitment	O
,	O
since	O
it	O
was	O
previously	O
found	O
that	O
adult	O
tenocytes	O
near	O
the	O
transection	O
site	O
undergo	O
apoptosis	O
shortly	O
after	O
injury20	O
.	O

However	O
,	O
Tunel	O
staining	O
for	O
apoptotic	O
cells	O
2	O
hours	O
after	O
injury	O
showed	O
intense	O
positive	O
staining	O
that	O
was	O
localized	O
to	O
regions	O
immediately	O
adjacent	O
to	O
the	O
cut	O
site	O
(	O
Supplementary	O
Fig	O
.	O

S3	O
),	O
similar	O
to	O
previous	O
reports	O
of	O
adult	O
injured	O
tendons	O
.	O

Collectively	O
,	O
our	O
results	O
suggest	O
that	O
neonatal	O
healing	O
is	O
mediated	O
by	O
transient	O
infiltration	O
of	O
αSMA	B-GP
+	O
cells	O
,	O
followed	O
by	O
proliferation	O
and	O
recruitment	O
of	O
intrinsic	O
Scxlin	O
tenocytes	O
.	O

In	O
contrast	O
,	O
adult	O
healing	O
is	O
solely	O
mediated	O
by	O
extrinsic	O
cells	O
that	O
persist	O
to	O
form	O
a	O
permanent	O
scar	O
.	O

Adult	O
tendon	O
undergoes	O
aberrant	O
differentiation	O
toward	O
cartilage	O
and	O
bone	O
after	O
injury	O

Since	O
aberrant	O
differentiation	O
has	O
been	O
reported	O
in	O
adult	O
tendons	O
after	O
transection	O
,	O
we	O
used	O
Alcian	O
Blue	O
staining	O
to	O
visualize	O
cartilage	O
.	O

Intense	O
cartilage	O
-	O
like	O
staining	O
was	O
observed	O
for	O
the	O
adult	O
injured	O
tendon	O
near	O
the	O
transection	O
site	O
at	O
d28	O
,	O
while	O
Alcian	O
Blue	O
staining	O
in	O
neonatal	O
injured	O
tendon	O
was	O
similar	O
to	O
controls	O
(	O
Fig	O
.	O
9A	O
).	O

Radiographs	O
showed	O
ectopic	O
bone	O
formation	O
in	O
adult	O
injured	O
tendons	O
at	O
d56	O
(	O
in	O
~	O
60	O
%	O
of	O
tendons	O
),	O
localized	O
specifically	O
within	O
the	O
tendon	O
stubs	O
(	O
Fig	O
.	O
9B	O
,	O
yellow	O
triangles	O
).	O

In	O
contrast	O
,	O
bone	O
was	O
never	O
observed	O
within	O
the	O
neonatal	O
injury	O
tendons	O
at	O
this	O
timepoint	O
.	O

Since	O
adult	O
tenocytes	O
appeared	O
to	O
be	O
activated	O
in	O
response	O
to	O
injury	O
(	O
indicated	O
by	O
upregulated	O
ScxGFP	O
expression	O
,	O
Fig	O
.	O
1	O
)	O
but	O
were	O
not	O
recruited	O
,	O
we	O
hypothesized	O
that	O
adult	O
cells	O
may	O
undergo	O
aberrant	O
differentiation	O
toward	O
chondrogenesis	O
at	O
the	O
expense	O
of	O
tenogenesis	O
.	O

To	O
determine	O
whether	O
the	O
ectopic	O
cartilage	O
in	O
adult	O
injured	O
tendon	O
was	O
derived	O
from	O
Scxlin	O
cells	O
,	O
we	O
again	O
used	O
ScxCreERT2	O
to	O
label	O
adult	O
tenocytes	O
prior	O
to	O
injury	O
and	O
harvested	O
limbs	O
at	O
d28	O
.	O

The	O
chondrogenic	O
mass	O
was	O
readily	O
identified	O
by	O
the	O
cobblestone	O
cell	O
morphology	O
and	O
absence	O
of	O
ScxGFP	O
expression	O
;	O
this	O
was	O
also	O
confirmed	O
by	O
Alcian	O
Blue	O
staining	O
of	O
alternate	O
adjacent	O
sections	O
.	O

Inspection	O
of	O
Scxlin	O
cells	O
within	O
the	O
sections	O
showed	O
that	O
Scxlin	O
cells	O
were	O
incorporated	O
within	O
the	O
chondrogenic	O
mass	O
,	O
although	O
numerous	O
non	O
-	O
Scxlin	O
cells	O
were	O
also	O
observed	O
(	O
Fig	O
.	O
9C	O
).	O

This	O
data	O
suggests	O
that	O
aberrant	O
differentiation	O
is	O
a	O
feature	O
of	O
adult	O
tendon	O
healing	O
but	O
not	O
neonatal	O
tendon	O
healing	O
,	O
further	O
highlighting	O
the	O
divergent	O
mechanisms	O
that	O
regulate	O
neonatal	O
vs	O
adult	O
tendon	O
healing	O
.	O

Discussion	O

To	O
date	O
,	O
only	O
a	O
few	O
tissues	O
have	O
been	O
tested	O
for	O
regenerative	O
healing	O
in	O
neonates	O
;	O
for	O
the	O
heart	O
and	O
digit	O
tips	O
,	O
neonatal	O
regeneration	O
is	O
driven	O
by	O
lineage	O
-	O
restricted	O
cells	O
,	O
while	O
regeneration	O
of	O
cochlear	O
hair	O
cells	O
also	O
depends	O
on	O
transdifferentiation	O
of	O
a	O
neighboring	O
supporting	O
cell	O
type11121314	O
.	O

Using	O
our	O
neonatal	O
injury	O
model	O
,	O
lineage	O
tracing	O
showed	O
that	O
tendon	O
regeneration	O
is	O
driven	O
by	O
tenocyte	O
proliferation	O
and	O
recruitment	O
from	O
the	O
original	O
tendon	O
stubs	O
.	O

In	O
contrast	O
,	O
adult	O
tenocytes	O
are	O
quiescent	O
after	O
injury	O
and	O
do	O
not	O
undergo	O
recruitment	O
;	O
in	O
the	O
absence	O
of	O
tenogenic	O
cells	O
,	O
adult	O
fibrotic	O
healing	O
is	O
mediated	O
by	O
αSMA	B-GP
-	O
expressing	O
cells	O
that	O
persist	O
to	O
form	O
a	O
permanent	O
scar	O
(	O
Fig	O
.	O
10	O
).	O

Our	O
results	O
suggest	O
that	O
the	O
intrinsic	O
potential	O
of	O
neonatal	O
tenocytes	O
(	O
which	O
are	O
still	O
mitotically	O
active	O
at	O
this	O
stage	O
and	O
relatively	O
immature	O
)	O
is	O
likely	O
very	O
different	O
compared	O
to	O
adult	O
tenocytes	O
,	O
which	O
are	O
post	O
-	O
mitotic	O
cells	O
.	O

It	O
can	O
be	O
difficult	O
to	O
conceptually	O
separate	O
development	O
vs	O
regeneration	O
at	O
this	O
stage	O
since	O
the	O
tissue	O
is	O
still	O
undergoing	O
dramatic	O
growth	O
(	O
although	O
the	O
key	O
events	O
of	O
cell	O
specification	O
,	O
differentiation	O
,	O
and	O
patterning	O
happen	O
during	O
embryonic	O
stages	O
)	O
2122	O
.	O

And	O
indeed	O
,	O
regeneration	O
often	O
recapitulates	O
many	O
aspects	O
of	O
tissue	O
development	O
.	O

For	O
example	O
,	O
in	O
the	O
case	O
of	O
regenerative	O
organisms	O
(	O
such	O
as	O
adult	O
salamanders	B-OG
)	O
or	O
tissues	O
(	O
such	O
as	O
bone	O
),	O
it	O
can	O
be	O
argued	O
that	O
the	O
regenerative	O
process	O
recapitulates	O
aspects	O
of	O
development	O
during	O
the	O
course	O
of	O
healing2324	O
.	O

Unlike	O
development	O
however	O
,	O
the	O
cells	O
driving	O
tissue	O
regeneration	O
are	O
more	O
restricted	O
in	O
their	O
lineage	O
potential	O
and	O
the	O
local	O
inflammatory	O
environment	O
plays	O
a	O
critical	O
role132526	O
.	O

Although	O
we	O
identified	O
tenocyte	O
recruitment	O
as	O
a	O
key	O
driver	O
of	O
neonatal	O
healing	O
,	O
we	O
cannot	O
yet	O
exclude	O
the	O
possibility	O
that	O
a	O
progenitor	O
/	O
stem	O
cell	O
type	O
may	O
also	O
be	O
activated	O
after	O
injury	O
.	O

Indeed	O
,	O
it	O
was	O
suggested	O
that	O
tendon	O
stem	O
cells	O
may	O
reside	O
within	O
the	O
tendon	O
proper27	O
;	O
therefore	O
,	O
recruited	O
cells	O
may	O
represent	O
a	O
specialized	O
sub	O
-	O
population	O
of	O
tenocytes	O
with	O
‘	O
stem	O
’	O
potential	O
.	O

Other	O
studies	O
however	O
,	O
suggest	O
that	O
tendon	O
stem	O
cells	O
may	O
reside	O
within	O
the	O
epitenon	O
/	O
paratenon	O
and	O
express	O
αSMA19282930	O
.	O

While	O
we	O
propose	O
here	O
that	O
αSMA	B-GP
+	O
cells	O
initially	O
form	O
a	O
transient	O
fibrotic	O
tissue	O
after	O
neonatal	O
tendon	O
injury	O
,	O
we	O
also	O
identified	O
a	O
small	O
subset	O
of	O
αSMA	B-GP
+	O
cells	O
within	O
the	O
neo	O
-	O
tendon	O
that	O
turned	O
on	O
ScxGFP	O
at	O
later	O
stages	O
.	O

Lineage	O
tracing	O
using	O
the	O
transgenic	O
αSMACreERT2	O
to	O
fate	O
map	O
this	O
population	O
was	O
attempted	O
,	O
but	O
the	O
extrinsic	O
αSMA	B-GP
cell	O
population	O
could	O
not	O
be	O
separated	O
from	O
neonatal	O
tenocytes	O
at	O
these	O
stages	O
due	O
to	O
extensive	O
Cre	B-GP
-	O
labeling	O
of	O
tenocytes	O
(	O
unpublished	O
data	O
).	O

This	O
labeling	O
likely	O
does	O
not	O
reflect	O
endogenous	O
expression	O
since	O
αSMA	B-GP
immunostaining	O
does	O
not	O
label	O
tenocytes	O
at	O
any	O
postnatal	O
stage	O
.	O

Although	O
αSMA	B-GP
staining	O
was	O
observed	O
in	O
the	O
epitenon	O
,	O
it	O
is	O
also	O
possible	O
that	O
these	O
cells	O
may	O
be	O
derived	O
from	O
multiple	O
external	O
sources31	O
.	O

Elucidating	O
the	O
roles	O
of	O
this	O
intriguing	O
cell	O
population	O
and	O
identifying	O
other	O
potential	O
cell	O
types	O
involved	O
in	O
regenerative	O
and	O
fibrotic	O
tendon	O
healing	O
will	O
be	O
the	O
focus	O
of	O
future	O
studies	O
.	O

One	O
interesting	O
feature	O
of	O
adult	O
tendon	O
healing	O
is	O
the	O
strong	O
re	O
-	O
activation	O
of	O
ScxGFP	O
expression	O
after	O
injury	O
and	O
aberrant	O
differentiation	O
toward	O
cartilage	O
and	O
bone	O
.	O

The	O
specific	O
localization	O
of	O
ScxGFP	O
re	O
-	O
expression	O
and	O
aberrant	O
cartilage	O
formation	O
to	O
the	O
tendon	O
stubs	O
suggest	O
that	O
these	O
events	O
may	O
be	O
interrelated	O
,	O
and	O
indeed	O
we	O
found	O
Scxlin	O
cells	O
within	O
the	O
cartilage	O
masses	O
,	O
consistent	O
with	O
two	O
recent	O
studies	O
that	O
also	O
show	O
a	O
contribution	O
of	O
tenocytes	O
to	O
heterotopic	O
ossification	O
,	O
either	O
in	O
the	O
context	O
of	O
injury	O
or	O
via	O
constitutive	O
activation	O
of	O
the	O
BMP	B-GP
receptor	I-GP
,	O
ACVR13233	B-GP
.	O

During	O
embryonic	O
development	O
,	O
an	O
early	O
pool	O
of	O
bipotent	O
Scx	B-GP
+	O
/	O
Sox9	B-GP
+	O
progenitors	O
give	O
rise	O
to	O
either	O
the	O
cartilage	O
or	O
tendon	O
components	O
of	O
the	O
skeletal	O
enthesis3435	O
.	O

We	O
speculate	O
that	O
re	O
-	O
activation	O
of	O
ScxGFP	O
after	O
injury	O
may	O
indicate	O
tenocyte	O
reversion	O
toward	O
a	O
progenitor	O
-	O
like	O
phenotype	O
;	O
adult	O
tenocytes	O
may	O
subsequently	O
undergo	O
chondrogenesis	O
in	O
response	O
to	O
abnormal	O
mechanical	O
loading	O
(	O
or	O
rather	O
,	O
unloading	O
)	O
associated	O
with	O
transection	O
injury	O
or	O
in	O
response	O
to	O
inflammatory	O
cues	O
.	O

Sensitivity	O
of	O
tenocytes	O
to	O
their	O
mechanical	O
environment	O
has	O
been	O
shown	O
in	O
several	O
studies	O
.	O

For	O
example	O
,	O
the	O
application	O
of	O
compressive	O
forces	O
in	O
tendon	O
can	O
induce	O
fibrocartilaginous	O
phenotypes	O
,	O
which	O
is	O
lost	O
when	O
the	O
mechanical	O
stimulation	O
is	O
removed3637	O
.	O

Inflammation	O
can	O
also	O
trigger	O
heterotopic	O
endochondral	O
ossification	O
,	O
as	O
established	O
by	O
several	O
studies	O
of	O
traumatic	O
or	O
neurogenic	O
injuries	O
and	O
congenital	B-DS
diseases383940	I-DS
.	O

In	O
addition	O
,	O
a	O
recent	O
study	O
showed	O
that	O
the	O
tendon	O
transcription	B-GP
factor	I-GP
Mkx	B-GP
may	O
also	O
function	O
to	O
inhibit	O
chondrogenic	O
differentiation	O
in	O
tenocytes	O
;	O
41	O
our	O
study	O
showed	O
downregulation	O
of	O
Mkx	B-GP
expression	O
after	O
adult	O
tendon	O
injury	O
,	O
which	O
may	O
permit	O
cartilage	O
differentiation	O
at	O
the	O
expense	O
of	O
tenogenesis	O
.	O

Although	O
our	O
lineage	O
tracing	O
results	O
showed	O
a	O
clear	O
contribution	O
of	O
Scxlin	O
tenocytes	O
to	O
ectopic	O
cartilage	O
,	O
we	O
also	O
observed	O
a	O
number	O
of	O
non	O
-	O
labeled	O
cells	O
.	O

This	O
may	O
be	O
due	O
to	O
incomplete	O
recombination	O
of	O
tenocytes	O
or	O
may	O
also	O
indicate	O
infiltration	O
of	O
extrinsic	O
cells	O
to	O
help	O
form	O
ectopic	O
cartilage	O
.	O

If	O
extrinsic	O
cells	O
are	O
recruited	O
to	O
the	O
stubs	O
,	O
the	O
specific	O
localization	O
of	O
the	O
ectopic	O
cartilage	O
to	O
regions	O
near	O
the	O
cut	O
site	O
suggests	O
that	O
chondrogenic	O
differentiation	O
of	O
extrinsic	O
cells	O
is	O
likely	O
driven	O
by	O
signals	O
from	O
the	O
injured	O
tendon	O
itself	O
or	O
immune	O
cells	O
that	O
home	O
to	O
those	O
regions	O
.	O

Overall	O
,	O
our	O
data	O
indicates	O
that	O
aberrant	O
differentiation	O
of	O
tenocytes	O
toward	O
cartilage	O
at	O
the	O
expense	O
of	O
tenogenic	O
recruitment	O
may	O
be	O
one	O
of	O
the	O
key	O
mechanisms	O
underlying	O
poor	O
adult	O
tendon	O
healing	O
.	O

Identifying	O
the	O
local	O
mechanical	O
or	O
molecular	O
signals	O
that	O
inhibit	O
tendon	O
cell	O
recruitment	O
into	O
the	O
defect	O
may	O
enable	O
targeted	O
therapies	O
to	O
induce	O
adult	O
tendon	O
regeneration	O
.	O

The	O
signaling	O
pathways	O
underlying	O
regenerative	O
and	O
fibrotic	O
tendon	O
healing	O
have	O
yet	O
to	O
be	O
elucidated	O
,	O
but	O
one	O
attractive	O
candidate	O
is	O
the	O
TGFβ	B-GP
/	O
BMP	B-GP
family	O
.	O

During	O
development	O
,	O
TGFβ	B-GP
signaling	O
is	O
essential	O
for	O
tendon	O
formation	O
and	O
it	O
is	O
well	O
established	O
that	O
TGFβ	B-GP
can	O
induce	O
tendon	O
markers	O
in	O
cell	O
culture	O
.	O

Interestingly	O
,	O
TGFβ	B-GP
can	O
also	O
drive	O
chondrogenic	O
differentiation	O
and	O
injection	O
of	O
TGFβ	B-GP
ligands	O
has	O
been	O
used	O
to	O
induce	O
cartilage	O
deposits	O
in	O
tendon	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
TGFβ	B-GP
in	O
ectopic	O
cartilage	O
formation	O
after	O
tendon	O
injury	O
as	O
well424344	O
.	O

In	O
the	O
context	O
of	O
injury	O
,	O
TGFβ	B-GP
has	O
also	O
been	O
implicated	O
as	O
a	O
potent	O
inducer	O
of	O
fibrosis	O
.	O

While	O
BMP	B-GP
signaling	O
generally	O
inhibits	O
tendon	O
during	O
development	O
(	O
while	O
inducing	O
cartilage	O
),	O
select	O
members	O
of	O
the	O
BMP	B-GP
family	O
(	O
BMPs	B-GP
12	O
,	O
13	O
,	O
and	O
14	O
)	O
may	O
drive	O
tendon	O
differentiation45464748	O
.	O

Future	O
studies	O
will	O
therefore	O
elucidate	O
the	O
specific	O
activities	O
of	O
TGFβ	B-GP
,	O
BMP	B-GP
,	O
and	O
their	O
downstream	O
signaling	O
and	O
interactions	O
in	O
tendon	O
regeneration	O
,	O
fibrosis	O
,	O
and	O
heterotopic	O
ossification	O
.	O

Neonates	O
demonstrated	O
full	O
recovery	O
of	O
all	O
functional	O
properties	O
tested	O
,	O
including	O
gait	O
and	O
tensile	O
properties	O
.	O

This	O
is	O
in	O
marked	O
contrast	O
with	O
adult	O
tendons	O
,	O
which	O
remain	O
functionally	O
impaired	O
after	O
injury	O
,	O
consistent	O
with	O
numerous	O
studies	O
in	O
the	O
literature4950515253	O
.	O

Since	O
function	O
is	O
the	O
gold	O
standard	O
by	O
which	O
tendon	O
healing	O
is	O
frequently	O
assessed	O
,	O
our	O
finding	O
of	O
improved	O
neonatal	O
tendon	O
function	O
is	O
exciting	O
and	O
comparable	O
to	O
other	O
existing	O
regenerative	O
tendon	O
models	O
,	O
such	O
as	O
MRL	O
/	O
MpJ	O
(	O
and	O
related	O
mouse	B-OG
strains	O
)	O
and	O
fetal	O
sheep	B-OG
,	O
which	O
also	O
recover	O
functional	O
properties	O
after	O
injury5455565758	O
.	O

Although	O
MRL	O
/	O
MpJ	O
and	O
related	O
strains	O
are	O
useful	O
models	O
of	O
adult	O
regeneration	O
in	O
specific	O
contexts	O
,	O
a	O
few	O
recent	O
studies	O
in	O
non	O
-	O
tendon	O
tissues	O
suggest	O
that	O
MRL	O
/	O
MpJ	O
may	O
exhibit	O
accelerated	O
wound	O
closure	O
via	O
excessive	O
scar	O
formation	O
rather	O
than	O
true	O
regeneration59606162	O
.	O

The	O
fetal	O
model	O
on	O
the	O
other	O
hand	O
is	O
technically	O
challenging	O
in	O
mice	B-OG
given	O
the	O
small	O
size	O
and	O
inaccessibility	O
of	O
mouse	B-OG
embryos	O
.	O

Our	O
neonatal	O
mouse	B-OG
model	O
overcomes	O
these	O
limitations	O
since	O
its	O
regenerative	O
potential	O
is	O
not	O
restricted	O
to	O
any	O
particular	O
strain	O
;	O
thus	O
,	O
we	O
can	O
test	O
gene	O
function	O
and	O
cellular	O
mechanisms	O
using	O
the	O
wide	O
range	O
of	O
genetic	O
tools	O
that	O
have	O
already	O
been	O
generated	O
for	O
mouse	B-OG
and	O
directly	O
compare	O
against	O
adult	O
non	O
-	O
regenerative	O
tendon	O
healing	O
within	O
the	O
same	O
genetic	O
background	O
.	O

Although	O
our	O
neonatal	O
tendon	O
regeneration	O
model	O
captures	O
key	O
aspects	O
of	O
tendon	O
differentiation	O
,	O
maturation	O
of	O
the	O
collagen	B-GP
matrix	O
is	O
not	O
restored	O
two	O
months	O
after	O
injury	O
,	O
despite	O
functional	O
recovery	O
.	O

Our	O
results	O
suggest	O
that	O
although	O
Mkx	B-GP
is	O
necessary	O
for	O
collagen	B-GP
maturation910	O
,	O
it	O
may	O
not	O
be	O
sufficient	O
(	O
since	O
we	O
do	O
find	O
significant	O
upregulation	O
of	O
Mkx	B-GP
after	O
neonatal	O
injury	O
)	O
or	O
may	O
not	O
be	O
expressed	O
to	O
sufficient	O
levels	O
.	O

Additional	O
factors	O
may	O
be	O
required	O
for	O
full	O
maturation	O
of	O
collagen	B-GP
structure	O
;	O
these	O
factors	O
may	O
include	O
type	O
V	O
,	O
XII	O
,	O
or	O
XIV	O
collagens	B-GP
or	O
non	O
-	O
collagenous	O
matrix	O
molecules	O
such	O
as	O
decorin	B-GP
and	O
fibromodulin636465	B-GP
.	O

An	O
additional	O
limitation	O
includes	O
the	O
choice	O
of	O
complete	O
Achilles	O
tendon	O
transection	O
injury	O
without	O
repair	O
,	O
which	O
is	O
less	O
representative	O
of	O
the	O
clinical	O
scenario	O
.	O

Tendon	O
ruptures	O
are	O
typically	O
preceded	O
by	O
accumulated	O
local	O
damage	O
caused	O
by	O
overuse	O
(	O
due	O
to	O
sports	O
activities	O
or	O
age	O
),	O
although	O
in	O
the	O
case	O
of	O
knife	O
wounds	O
,	O
laceration	O
of	O
healthy	O
tendons	O
can	O
also	O
occur66	O
.	O

Several	O
overuse	O
models	O
have	O
been	O
developed	O
for	O
mouse	B-OG
tendon6768	O
,	O
however	O
these	O
models	O
are	O
not	O
readily	O
adapted	O
to	O
the	O
neonatal	O
mouse	B-OG
and	O
the	O
narrow	O
time	O
window	O
required	O
for	O
regenerative	O
healing	O
.	O

The	O
advantages	O
of	O
full	O
transection	O
is	O
experimental	O
feasibility	O
during	O
these	O
early	O
postnatal	O
stages	O
,	O
high	O
reproducibility	O
,	O
and	O
the	O
large	O
number	O
of	O
studies	O
using	O
this	O
model	O
for	O
adult	O
tendon	O
healing	O
in	O
the	O
literature	O
.	O

For	O
studies	O
of	O
basic	O
tendon	O
biology	O
,	O
our	O
neonatal	O
model	O
for	O
tendon	O
regeneration	O
holds	O
exciting	O
promise	O
for	O
establishing	O
important	O
cell	O
and	O
molecular	O
events	O
that	O
regulate	O
tendon	O
differentiation	O
,	O
with	O
the	O
potential	O
to	O
inform	O
adult	O
healing	O
and	O
the	O
development	O
of	O
new	O
therapies	O
.	O

Methods	O

Mice	B-OG

Existing	O
mouse	B-OG
lines	O
were	O
used	O
in	O
these	O
studies	O
:	O
ScxGFP	O
tendon	O
reporter69	O
,	O
ScxCreERT2	O
(	O
generated	O
by	O
Dr	O
.	O
Ronen	O
Schweitzer	O
),	O
and	O
the	O
Ai14	O
Rosa26	O
-	O
TdTomato	B-GP
Cre	B-GP
reporter70	O
.	O

Lineage	O
tracing	O
was	O
carried	O
out	O
by	O
tamoxifen	O
administration	O
prior	O
to	O
injury	O
.	O

Tamoxifen	O
in	O
corn	O
oil	O
was	O
given	O
to	O
neonates	O
by	O
gavage	O
(	O
1	O
.	O
25	O
mg	O
/	O
pup	O
for	O
2	O
consecutive	O
days	O
,	O
followed	O
by	O
2	O
days	O
rest	O
)	O
and	O
to	O
adults	O
by	O
daily	O
intraperitoneal	O
injections	O
(	O
100	O
mg	O
/	O
kg	O
wt	O
for	O
3	O
consecutive	O
days	O
followed	O
by	O
2	O
days	O
rest	O
).	O

EdU	O
was	O
given	O
at	O
0	O
.	O
05	O
mg	O
2	O
hr	O
prior	O
to	O
harvest	O
to	O
label	O
proliferating	O
cells	O
.	O

All	O
animal	B-OG
procedures	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	B-OG
Care	O
and	O
Use	O
Committee	O
and	O
Icahn	O
School	O
of	O
Medicine	O
at	O
Mount	O
Sinai	O
and	O
are	O
consistent	O
with	O
animal	B-OG
care	O
guidelines	O
.	O

Tendon	O
injury	O
model	O

For	O
all	O
studies	O
,	O
neonatal	O
(	O
P5	O
)	O
and	O
adult	O
(	O
4	O
–	O
5	O
month	O
old	O
)	O
mice	B-OG
were	O
anesthetized	O
by	O
hypothermia	O
or	O
isofluorane	O
inhalation	O
,	O
respectively	O
.	O

A	O
small	O
incision	O
was	O
made	O
in	O
the	O
skin	O
of	O
right	O
hindlimbs	O
to	O
expose	O
the	O
Achilles	O
tendon	O
,	O
followed	O
by	O
complete	O
transection	O
of	O
the	O
Achilles	O
tendon	O
at	O
the	O
midsubstance	O
.	O

The	O
left	O
contralateral	O
limb	O
was	O
used	O
as	O
controls	O
.	O

After	O
injury	O
,	O
the	O
skin	O
was	O
closed	O
using	O
Prolene	O
sutures	O
and	O
animals	B-OG
returned	O
to	O
full	O
cage	O
activity	O
.	O

Male	O
and	O
female	O
mice	B-OG
were	O
distributed	O
evenly	O
between	O
groups	O
.	O

RNA	O
isolation	O
,	O
reverse	O
transcription	O
,	O
and	O
qRT	O
-	O
PCR	O

Total	O
RNAs	O
were	O
extracted	O
from	O
contralateral	O
control	O
or	O
injured	O
Achilles	O
tendons	O
after	O
neonatal	O
or	O
adult	O
injury	O
using	O
Trizol	O
/	O
chloroform	O
and	O
quantified	O
using	O
NanoDrop	O
2000	O
.	O

Reverse	O
transcription	O
was	O
carried	O
out	O
using	O
SuperScript	O
VILO	O
Master	O
Mix	O
and	O
qRT	O
-	O
PCR	O
performed	O
using	O
SYBR	O
Green	O
PCR	O
Master	O
Mix	O
(	O
Thermo	O
Fisher	O
).	O

The	O
primer	O
sequences	O
used	O
are	O
listed	O
in	O
Supplementary	O
Table	O
S2	O
.	O

RNA	O
samples	O
were	O
prepared	O
from	O
5	O
–	O
7	O
independent	O
samples	O
and	O
ran	O
in	O
triplicate	O
.	O

Functional	O
gait	O
analysis	O

DigiGait	O
Imaging	O
System	O
and	O
software	O
(	O
Mouse	B-OG
Specifics	O
Inc	O
.,	O
Quincy	O
,	O
MA	O
)	O
were	O
used	O
to	O
analyze	O
functional	O
gait	O
recovery	O
following	O
injury	O
.	O

Without	O
pretraining	O
,	O
mice	B-OG
were	O
gaited	O
at	O
5	O
cm	O
/	O
s	O
for	O
3	O
–	O
4	O
s	O
on	O
a	O
transparent	O
treadmill	O
and	O
a	O
high	O
-	O
speed	O
digital	O
camera	O
used	O
to	O
capture	O
the	O
position	O
of	O
each	O
paw	O
.	O

Footage	O
was	O
analyzed	O
using	O
the	O
Digigait	O
Analysis	O
Software	O
(	O
Digigait	O
12	O
.	O
4	O
).	O

Measurements	O
from	O
the	O
hindlimbs	O
were	O
used	O
to	O
calculate	O
%	O
SwingStride	O
,	O
%	O
BrakeStride	O
and	O
%	O
PropelStride	O
(	O
all	O
parameters	O
were	O
normalized	O
to	O
Stride	O
Length	O
to	O
account	O
for	O
differences	O
in	O
animal	B-OG
size	O
due	O
to	O
sex	O
or	O
age	O
).	O

Injured	O
and	O
non	O
-	O
injured	O
age	O
-	O
matched	O
mice	B-OG
were	O
used	O
to	O
establish	O
gait	O
parameters	O
associated	O
with	O
injury	O
and	O
healing	O
(	O
n	O
=	O
5	O
–	O
8	O
per	O
group	O
).	O

Biomechanical	O
testing	O
and	O
analysis	O

Mechanical	O
testing	O
of	O
mouse	B-OG
Achilles	O
tendons	O
was	O
performed	O
using	O
custom	O
grips	O
to	O
clamp	O
the	O
calcaneus	O
bone	O
and	O
Achilles	O
tendon	O
.	O

The	O
tissue	O
was	O
then	O
immersed	O
in	O
a	O
PBS	O
bath	O
at	O
room	O
temperature	O
and	O
preloaded	O
to	O
0	O
.	O
05	O
N	O
for	O
~	O
1	O
min	O
followed	O
by	O
ramp	O
to	O
failure	O
at	O
1	O
%/	O
s	O
.	O

The	O
maximum	O
force	O
,	O
stiffness	O
and	O
elongation	O
at	O
yield	O
were	O
recorded	O
for	O
both	O
injured	O
and	O
uninjured	O
tendons	O
.	O

Material	O
properties	O
were	O
not	O
calculated	O
since	O
cross	O
-	O
sectional	O
area	O
could	O
not	O
be	O
accurately	O
measured	O
in	O
tissues	O
of	O
this	O
size	O
.	O

Mechanical	O
testing	O
was	O
carried	O
out	O
for	O
n	O
=	O
10	O
independent	O
samples	O
per	O
group	O
.	O

Transmission	O
electron	O
microscopy	O

Whole	O
mouse	B-OG
hindlimbs	O
were	O
fixed	O
in	O
1	O
.	O
5	O
%	O
glutaraldehyde	O
/	O
1	O
.	O
5	O
%	O
paraformaldehyde	O
(	O
Tousimis	O
Research	O
Corporation	O
)	O
in	O
Dulbecco	O
’	O
s	O
serum	O
-	O
free	O
media	O
(	O
SFM	O
)	O
containing	O
0	O
.	O
05	O
%	O
tannic	O
acid	O
,	O
followed	O
by	O
an	O
extensive	O
rinse	O
in	O
SFM	O
,	O
then	O
post	O
-	O
fixation	O
in	O
1	O
%	O
OsO4	O
Samples	O
were	O
washed	O
in	O
SFM	O
then	O
dehydrated	O
in	O
a	O
graded	O
series	O
of	O
ethanol	O
to	O
100	O
%,	O
rinsed	O
in	O
propylene	O
oxide	O
,	O
and	O
infiltrated	O
in	O
Spurrs	O
epoxy	O
.	O

Samples	O
were	O
polymerized	O
at	O
70	O
C	O
over	O
18	O
h	O
.	O

TEM	O
images	O
of	O
transverse	O
sections	O
were	O
collected	O
at	O
several	O
magnifications	O
to	O
enable	O
morphological	O
visualization	O
of	O
the	O
collagen	B-GP
fibrils	O
and	O
gross	O
tendon	O
appearance	O
.	O

Collagen	B-GP
fibril	O
diameters	O
were	O
determined	O
using	O
Image	O
J	O
software	O
(	O
NIH	O
);	O
six	O
representative	O
images	O
were	O
analyzed	O
for	O
each	O
tendon	O
(	O
n	O
=	O
3	O
independent	O
samples	O
per	O
group	O
)	O
and	O
a	O
total	O
of	O
1200	O
fibrils	O
analyzed	O
per	O
sample	O
.	O

Whole	O
mount	O
fluorescence	O
imaging	O

Whole	O
mount	O
imaging	O
was	O
carried	O
out	O
for	O
whole	O
limbs	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
with	O
skin	O
removed	O
.	O

Images	O
were	O
acquired	O
using	O
a	O
Leica	O
stereomicroscope	O
with	O
fluorescence	O
capabilities	O
(	O
Leica	O
M165FC	O
).	O

Histology	O
and	O
immunofluorescence	O

For	O
fluorescence	O
imaging	O
,	O
immunofluorescence	O
,	O
and	O
in	O
situ	O
hybridization	O
of	O
sections	O
,	O
hindlimbs	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
and	O
frozen	O
in	O
OCT	O
medium	O
.	O

Alternating	O
transverse	O
cryosections	O
(	O
12	O
μm	O
)	O
were	O
collected	O
across	O
the	O
length	O
of	O
the	O
limb	O
to	O
capture	O
the	O
trajectory	O
of	O
the	O
Achilles	O
tendon	O
from	O
skeletal	O
insertion	O
to	O
muscle	O
.	O

Immunostaining	O
was	O
carried	O
out	O
using	O
antibodies	B-GP
against	O
laminin	B-GP
(	O
Sigma	O
)	O
and	O
α	B-GP
-	I-GP
smooth	I-GP
muscle	I-GP
actin	I-GP
(	O
Sigma	O
)	O
with	O
Cy3	O
or	O
Cy5	O
secondary	O
detection	O
(	O
Jackson	O
ImmunoResearch	O
),	O
with	O
DAPI	O
counterstaining	O
to	O
visualize	O
cell	O
nuclei	O
.	O

EdU	O
and	O
Tunel	O
assays	O
were	O
performed	O
using	O
the	O
Click	O
it	O
EdU	O
(	O
Life	O
Technologies	O
)	O
and	O
In	O
Situ	O
Cell	O
Death	O
Detection	O
kits	O
(	O
Roche	O
),	O
respectively	O
,	O
according	O
to	O
manufacturer	O
’	O
s	O
instructions	O
.	O

For	O
analysis	O
of	O
longitudinal	O
sections	O
,	O
hindlimbs	O
were	O
fixed	O
in	O
zinc	O
formalin	O
,	O
dehydrated	O
,	O
and	O
infiltrated	O
with	O
methacrylate	O
monomer	O
and	O
embedded	O
.	O

Plastic	O
sections	O
were	O
then	O
acquired	O
at	O
6	O
μm	O
,	O
stained	O
with	O
Picrosirius	O
Red	O
,	O
and	O
imaged	O
with	O
polarized	O
light	O
to	O
visualize	O
collagen	B-GP
alignment	O
.	O

Additional	O
sections	O
were	O
immunostained	O
for	O
type	O
I	O
and	O
III	O
collagens	B-GP
(	O
Abcam	O
)	O
with	O
DAB	O
Chromagen	O
secondary	O
detection	O
(	O
Vector	O
Laboratories	O
)	O
and	O
counterstained	O
with	O
Toluidine	O
Blue	O
.	O

All	O
images	O
were	O
acquired	O
using	O
Zeiss	O
Axio	O
Imager	O
microscope	O
;	O
an	O
Apotome	O
was	O
used	O
for	O
optical	O
sectioning	O
of	O
fluorescent	O
images	O
.	O

Statistics	O

All	O
quantitative	O
results	O
are	O
presented	O
as	O
mean	O
±	O
standard	O
deviation	O
.	O

For	O
qRT	O
-	O
PCR	O
analysis	O
,	O
statistics	O
were	O
carried	O
out	O
using	O
two	O
way	O
ANOVA	O
with	O
Tukey	O
’	O
s	O
posthoc	O
testing	O
(	O
independent	O
variables	O
of	O
time	O
and	O
injury	O
condition	O
,	O
Systat	O
Software	O
).	O

Cell	O
proliferation	O
quantification	O
was	O
analyzed	O
using	O
one	O
way	O
ANOVA	O
.	O

All	O
other	O
quantitative	O
analyses	O
were	O
carried	O
out	O
using	O
paired	O
Students	O
t	O
-	O
tests	O
between	O
control	O
and	O
injured	O
samples	O
.	O

Significant	O
outliers	O
were	O
detected	O
and	O
discarded	O
using	O
the	O
Grubbs	O
’	O
test	O
(	O
Graphpad	O
,	O
α	O
=	O
0	O
.	O
05	O
).	O

Additional	O
Information	O

How	O
to	O
cite	O
this	O
article	O
:	O
Howell	O
,	O
K	O
.	O
et	O
al	O
.	O

Novel	O
Model	O
of	O
Tendon	O
Regeneration	O
Reveals	O
Distinct	O
Cell	O
Mechanisms	O
Underlying	O
Regenerative	O
and	O
Fibrotic	O
Tendon	O
Healing	O
.	O
Sci	O
.	O

Rep	O
.	O
7	O
,	O
45238	O
;	O
doi	O
:	O
10	O
.	O
1038	O
/	O
srep45238	O
(	O
2017	O
).	O

Publisher	O
'	O
s	O
note	O
:	O
Springer	O
Nature	O
remains	O
neutral	O
with	O
regard	O
to	O
jurisdictional	O
claims	O
in	O
published	O
maps	O
and	O
institutional	O
affiliations	O
.	O

Supplementary	O
Material	O

Supplementary	O
Figures	O
and	O
Tables	O

Supplementary	O
Video	O
1	O

Supplementary	O
Video	O
2	O

Supplementary	O
Video	O
3	O

Supplementary	O
Video	O
4	O

The	O
authors	O
declare	O
no	O
competing	O
financial	O
interests	O
.	O

Author	O
Contributions	O
K	O
.	O
H	O
.,	O
C	O
.	O
C	O
.,	O
D	O
.	O
L	O
.,	O
and	O
A	O
.	O
H	O
.	O
H	O
.	O
contributed	O
to	O
experiments	O
,	O
data	O
collection	O
,	O
and	O
analysis	O
.	O

A	O
.	O
H	O
.	O
H	O
.	O
contributed	O
to	O
conception	O
of	O
experiments	O
and	O
data	O
interpretation	O
.	O

S	O
.	O
F	O
.	O
T	O
.,	O
D	O
.	O
R	O
.	O
K	O
.,	O
and	O
K	O
.	O
H	O
.	O
contributed	O
to	O
TEM	O
data	O
collection	O
and	O
analysis	O
.	O

N	O
.	O
A	O
.	O
P	O
.	O
and	O
R	O
.	O
B	O
.	O
designed	O
and	O
carried	O
out	O
mechanical	O
testing	O
and	O
analysis	O
.	O

K	O
.	O
H	O
.	O
and	O
A	O
.	O
H	O
.	O
H	O
.	O
prepared	O
and	O
edited	O
the	O
manuscript	O
prior	O
to	O
submission	O
.	O

(	O
A	O
)	O
Schematic	O
and	O
whole	O
mount	O
images	O
of	O
Achilles	O
tendon	O
transection	O
injury	O
model	O
using	O
ScxGFP	O
mice	O
.	O

(	O
B	O
)	O
Video	O
still	O
frames	O
of	O
neonatal	O
mice	O
at	O
d3	O
and	O
d14	O
after	O
P5	O
injury	O
.	O

Complete	O
videos	O
can	O
be	O
found	O
in	O
Supplementary	O
Data	O
.	O

Red	O
arrows	O
indicate	O
injured	O
limb	O
and	O
comparable	O
control	O
limb	O
in	O
non	O
-	O
injured	O
animals	O
to	O
highlight	O
abnormal	O
gait	O
.	O

Whole	O
mount	O
images	O
of	O
control	O
and	O
injured	O
ScxGFP	O
limbs	O
at	O
(	O
C	O
)	O
d3	O
and	O
(	O
D	O
)	O
d14	O
after	O
neonatal	O
injury	O
.	O

White	O
triangles	O
indicate	O
intact	O
tendon	O
and	O
transected	O
tendon	O
stubs	O
.	O

Yellow	O
triangles	O
indicate	O
gap	O
space	O
at	O
d3	O
and	O
ScxGFP	O
+	O
neo	O
-	O
tendon	O
at	O
d14	O
.	O

(	O
E	O
)	O
Whole	O
mount	O
images	O
of	O
control	O
and	O
injured	O
ScxGFP	O
limbs	O
at	O
d14	O
after	O
adult	O
injury	O
.	O

White	O
triangles	O
indicate	O
intact	O
tendon	O
and	O
transected	O
tendon	O
stubs	O
while	O
yellow	O
triangle	O
indicates	O
ScxGFP	O
-	O
negative	O
scar	O
tissue	O
.	O

Real	O
time	O
qPCR	O
of	O
(	O
A	O
)	O
tendon	O
markers	O
,	O
(	O
B	O
)	O
cartilage	O
,	O
bone	O
,	O
and	O
fat	O
markers	O
,	O
and	O
(	O
C	O
)	O
scar	O
-	O
associated	O
markers	O
in	O
control	O
and	O
injured	O
neonatal	O
tendons	O
.	O
*	O
Indicates	O
significant	O
difference	O
relative	O
to	O
control	O
within	O
timepoint	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O
n	O
.	O
s	O
.	O
indicates	O
no	O
significance	O
relative	O
to	O
control	O
(	O
p	O
>	O
0	O
.	O
1	O
).	O
n	O
=	O
5	O
–	O
7	O
tendons	O
/	O
group	O
.	O

(	O
A	O
)	O
Schematic	O
and	O
(	O
B	O
)	O
idealized	O
graph	O
defining	O
gait	O
parameter	O
measurements	O
(	O
adapted	O
from	O
Digigait	O
Imaging	O
Systems	O
).	O

(	O
C	O
)	O
Adult	O
gait	O
parameters	O
tested	O
from	O
d3	O
to	O
d28	O
after	O
injury	O
.	O

(	O
D	O
)	O
Neonatal	O
gait	O
parameters	O
tested	O
at	O
d14	O
and	O
d28	O
after	O
injury	O
.	O
*	O
Indicates	O
significant	O
difference	O
relative	O
to	O
control	O
limb	O
within	O
timepoint	O
.	O
n	O
=	O
5	O
mice	O
/	O
group	O
.	O

(	O
E	O
)	O
Tensile	O
properties	O
maximum	O
force	O
,	O
stiffness	O
,	O
and	O
yield	O
elongation	O
at	O
d56	O
after	O
adult	O
and	O
neonatal	O
injury	O
.	O
*	O
Indicates	O
significant	O
difference	O
relative	O
to	O
contralateral	O
control	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O
n	O
.	O
s	O
.	O
indicates	O
no	O
significance	O
relative	O
to	O
control	O
(	O
p	O
>	O
0	O
.	O
1	O
).	O
n	O
=	O
10	O
tendons	O
/	O
group	O
.	O

TEM	O
imaging	O
of	O
(	O
A	O
)	O
neonatal	O
and	O
(	O
B	O
)	O
adult	O
tendon	O
cross	O
-	O
sections	O
at	O
d56	O
.	O

Red	O
arrows	O
indicate	O
disorganized	O
,	O
noncollagenous	O
matrix	O
.	O

Quantification	O
of	O
(	O
C	O
)	O
neonatal	O
and	O
(	O
D	O
)	O
adult	O
collagen	O
fibril	O
diameter	O
in	O
control	O
and	O
injured	O
tendons	O
at	O
d56	O
,	O
using	O
high	O
magnification	O
TEM	O
images	O
(	O
insets	O
).	O

Fibrils	O
were	O
counted	O
from	O
n	O
=	O
3	O
mice	O
/	O
group	O
(	O
1200	O
fibrils	O
/	O
tendon	O
).	O

(	O
E	O
)	O
Picrosirius	O
red	O
staining	O
and	O
polarized	O
light	O
imaging	O
of	O
longitudinal	O
neonatal	O
tendon	O
sections	O
at	O
d56	O
.	O

Green	O
color	O
indicates	O
thinner	O
fibrils	O
while	O
red	O
/	O
orange	O
color	O
indicates	O
thicker	O
fibrils	O
.	O

Immunostaining	O
for	O
(	O
F	O
)	O
type	O
III	O
and	O
(	O
G	O
)	O
type	O
I	O
collagens	O
in	O
longitudinal	O
neonatal	O
tendon	O
sections	O
at	O
d56	O
.	O

Red	O
arrowheads	O
highlight	O
positive	O
staining	O
in	O
(	O
F	O
).	O

(	O
A	O
)	O
Schematic	O
image	O
and	O
(	O
B	O
)	O
transverse	O
sections	O
of	O
neonatal	O
ScxGFP	O
hindlimb	O
immunostained	O
for	O
laminin	O
or	O
αSMA	O
at	O
d14	O
after	O
injury	O
.	O

Yellow	O
borders	O
delineate	O
ScxGFP	O
+	O
neo	O
-	O
tendon	O
in	O
(	O
B	O
).	O

(	O
C	O
)	O
Schematic	O
image	O
and	O
(	O
D	O
)	O
transverse	O
sections	O
of	O
adult	O
ScxGFP	O
hindlimb	O
stained	O
for	O
laminin	O
or	O
αSMA	O
.	O

Scalebar	O
:	O
100	O
μm	O
.	O

(	O
A	O
)	O
Schematic	O
image	O
of	O
transected	O
tendon	O
at	O
d3	O
depicting	O
section	O
levels	O
.	O

(	O
B	O
)	O
Transverse	O
sections	O
from	O
ScxGFP	O
limb	O
at	O
d3	O
after	O
injury	O
at	O
levels	O
L1	O
-	O
L3	O
shown	O
in	O
(	O
A	O
),	O
immunostained	O
for	O
αSMA	O
and	O
counterstained	O
with	O
DAPI	O
for	O
cell	O
nuclei	O
.	O

Injured	O
Achilles	O
tendon	O
and	O
adjacent	O
non	O
-	O
injured	O
tendon	O
highlighted	O
by	O
red	O
and	O
orange	O
arrows	O
,	O
respectively	O
.	O

Scalebar	O
:	O
100	O
μm	O
.	O

(	O
A	O
)	O
Schematic	O
image	O
of	O
transected	O
tendon	O
at	O
d3	O
after	O
injury	O
depicting	O
levels	O
L1	O
and	O
L2	O
through	O
which	O
(	O
B	O
,	O
C	O
)	O
transverse	O
sections	O
were	O
taken	O
.	O

(	O
B	O
)	O
EdU	O
labeling	O
of	O
proliferating	O
cells	O
in	O
control	O
and	O
injured	O
ScxGFP	O
limbs	O
at	O
d3	O
after	O
neonatal	O
injury	O
.	O

(	O
C	O
)	O
EdU	O
labeling	O
of	O
proliferating	O
cells	O
(	O
white	O
arrows	O
)	O
in	O
control	O
and	O
injured	O
ScxGFP	O
limbs	O
at	O
d3	O
after	O
adult	O
injury	O
.	O

Yellow	O
borders	O
delineate	O
neonatal	O
and	O
adult	O
tendon	O
stubs	O
in	O
(	O
B	O
,	O
C	O
).	O

(	O
D	O
,	O
E	O
)	O
Quantification	O
of	O
proliferating	O
cells	O
after	O
neonatal	O
and	O
adult	O
injury	O
.	O

Data	O
are	O
plotted	O
as	O
%	O
EdU	O
+	O
cells	O
relative	O
to	O
total	O
cells	O
within	O
tendon	O
stub	O
and	O
%	O
ScxGFP	O
+	O
/	O
EdU	O
+	O
cells	O
relative	O
to	O
total	O
EdU	O
+	O
cells	O
within	O
tendon	O
stub	O
.	O
*	O
Indicates	O
signficant	O
differences	O
relative	O
to	O
all	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Scalebar	O
:	O
100	O
μm	O
.	O

(	O
A	O
)	O
Potential	O
models	O
of	O
tendon	O
healing	O
.	O

Neonatal	O
:	O
neo	O
-	O
tendon	O
formation	O
and	O
tenogenic	O
differentiation	O
is	O
driven	O
by	O
intrinsic	O
tenocytes	O
OR	O
extrinsic	O
cells	O
.	O

Adult	O
:	O
scar	O
formation	O
originates	O
from	O
intrinsic	O
tenocytes	O
OR	O
extrinsic	O
cells	O
.	O

(	O
B	O
)	O
Schematic	O
image	O
and	O
(	O
C	O
)	O
whole	O
mount	O
and	O
transverse	O
sections	O
of	O
ScxCreERT2	O
/	O
RosaT	O
/	O
ScxGFP	O
neonatal	O
limbs	O
at	O
d28	O
after	O
injury	O
.	O

Tenocytes	O
were	O
labeled	O
by	O
tamoxifen	O
injection	O
prior	O
to	O
injury	O
.	O

(	O
D	O
)	O
Schematic	O
image	O
and	O
(	O
E	O
)	O
transverse	O
sections	O
of	O
ScxCreERT2	O
/	O
RosaT	O
/	O
ScxGFP	O
adult	O
limbs	O
at	O
d28	O
after	O
injury	O
.	O

Tenocytes	O
were	O
labeled	O
by	O
tamoxifen	O
injection	O
prior	O
to	O
injury	O
.	O

DAPI	O
staining	O
shows	O
presence	O
of	O
numerous	O
cells	O
.	O

(	O
F	O
)	O
Schematic	O
image	O
of	O
transected	O
neonatal	O
tendon	O
at	O
d3	O
after	O
injury	O
depicting	O
levels	O
L1	O
and	O
L2	O
through	O
which	O
(	O
G	O
)	O
transverse	O
sections	O
were	O
taken	O
.	O

(	O
G	O
)	O
EdU	O
detection	O
of	O
proliferating	O
cells	O
in	O
tamoxifen	O
-	O
labeled	O
control	O
and	O
injured	O
ScxCreERT2	O
/	O
RosaT	O
/	O
ScxGFP	O
limbs	O
at	O
d3	O
.	O

Injured	O
Achilles	O
tendon	O
and	O
adjacent	O
non	O
-	O
injured	O
tendon	O
highlighted	O
by	O
red	O
and	O
orange	O
arrows	O
,	O
respectively	O
.	O

(	O
H	O
)	O
Quantification	O
of	O
EdU	O
+	O
and	O
EdU	O
+/	O
Scxlin	O
cells	O
in	O
alternate	O
serial	O
transverse	O
sections	O
from	O
insertion	O
into	O
gap	O
space	O
at	O
d3	O
after	O
neonatal	O
injury	O
from	O
a	O
representative	O
tendon	O
.	O

Scalebar	O
:	O
100	O
μm	O
.	O

(	O
A	O
)	O
Alcian	O
blue	O
cartilage	O
staining	O
of	O
transverse	O
tendon	O
sections	O
from	O
control	O
and	O
injured	O
limbs	O
at	O
d28	O
after	O
neonatal	O
or	O
adult	O
injury	O
.	O

Red	O
arrows	O
highlight	O
ectopic	O
cartilage	O
.	O

(	O
B	O
)	O
Radiographs	O
of	O
whole	O
limbs	O
detect	O
ectopic	O
ossification	O
at	O
d56	O
in	O
adult	O
tendon	O
stubs	O
(	O
yellow	O
triangles	O
).	O

(	O
C	O
)	O
Transverse	O
sections	O
through	O
ScxCreERT2	O
-	O
labeled	O
tendons	O
show	O
contribution	O
of	O
labeled	O
(	O
red	O
)	O
cells	O
in	O
regions	O
corresponding	O
to	O
ectopic	O
cartilage	O
(	O
white	O
arrows	O
).	O

Alcian	O
Blue	O
staining	O
of	O
adjacent	O
section	O
confirms	O
cartilage	O
deposition	O
and	O
morphology	O
.	O

Scalebar	O
:	O
100	O
μm	O
.	O

Neonatal	O
regenerative	O
tendon	O
healing	O
is	O
driven	O
by	O
early	O
and	O
transient	O
recruitment	O
of	O
an	O
extrinsic	O
αSMA	O
cell	O
population	O
,	O
followed	O
by	O
tenocyte	O
recruitment	O
,	O
differentiation	O
,	O
and	O
restoration	O
of	O
function	O
.	O

In	O
contrast	O
,	O
adult	O
tenocytes	O
are	O
activated	O
but	O
not	O
recruited	O
.	O

Instead	O
,	O
tenocytes	O
contribute	O
to	O
ectopic	O
cartilage	O
formation	O
in	O
tendon	O
stubs	O
.	O

In	O
the	O
absence	O
of	O
tenogenic	O
cell	O
recruitment	O
,	O
αSMA	O
cells	O
persist	O
to	O
form	O
a	O
permanent	O
scar	O
with	O
impaired	O
functional	O
properties	O
.	O

